Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies
This clinical trial update describes tissue acquisition and genomics analysis of breast cancer and other gynecologic malignancies, with enro…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Prediction of Germline BRCA 1/2 Genes From Healthy Ovaries
A clinical trial is exploring predicting germline BRCA1/2 gene status from healthy ovarian tissue and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Ovarian Tumor Organotypic Slices Cultures for functionAl Drug Testing and Therapy Response Prediction [NA]
This clinical trial update describes a study using ovarian tumor organotypic slice cultures to functionally test drugs and predict therapy r…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer [Phase 2]
Phase 2 clinical trial evaluating autologous T cells engineered to express T-cell receptors against neoantigens in metastatic cancer, curren…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Intervention of Ovarian Cancer With Antigen-specific Engineered Immune Effectors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating antigen-specific engineered immune effectors for ovarian cancer is currently enrolling by invitation.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer [Phase 1]
Phase 1 trial evaluating adding abemaciclib to olaparib in women with recurrent ovarian cancer, including high-grade serous and platinum-res…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Tiaoshen Anti-cancer Protocol and CBT for Insomnia and Survival in Ovarian Cancer [Phase 2, Phase 3]
Clinical trial update describing a phase 2/3 study of the Tiaoshen anti-cancer protocol combined with cognitive behavioral therapy for insom…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial) [Phase 2]
Phase 2 ComboMATCH trial evaluating neratinib alone or with palbociclib for HER2-positive solid tumors, including malignant neoplasms of the…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial [Phase 2]
Phase 2 screening trial (ComboMATCH) sponsored by the National Cancer Institute uses genetic testing to direct targeted therapies for patien…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Setting Up ctDNA Analysis on Archived Plasma Samples
The update describes a study to establish ctDNA analysis on archived plasma samples for ovarian cancer, with the trial currently active but …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study Evaluating Safety, Tolerability, and Metabolism of Niraparib [Phase 4]
A Phase 4 clinical trial evaluating safety, tolerability, and metabolism of Niraparib in ovarian cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021) [Phase 3]
This update reports an ongoing Phase 3 clinical trial of Sac-TMT for non-HRD positive advanced ovarian cancer that is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Randomized Controlled Trial Evaluating the Feasibility and Preliminary Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Advanced Epithelial Ovarian Cancer [NA]
A randomized controlled trial evaluating the feasibility and preliminary efficacy of pressurized intraperitoneal aerosol chemotherapy (PIPAC…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression [Phase 3]
Phase 3 trial to compare Azenosertib (ZN-c3) against investigator's choice chemotherapy in platinum-resistant high-grade serous ovarian, pri…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant Tumors [Phase 2]
Phase II clinical trial evaluating HLX43, an anti-PD-L1 antibody-drug conjugate, for advanced gynecologic cancers; currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors [Phase 1]
BeiGene is conducting a Phase 1 safety study to evaluate different doses of BG-68501 in participants with various advanced-stage cancers, an…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Non-interventional Study to Collect Real-world Clinical and Patient-reported Outcomes in Ovarian Cancer
This is a non-interventional, real-world study sponsored by AstraZeneca to collect clinical and patient-reported outcomes in ovarian cancer;…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial [Phase 2]
Phase 2 study evaluating the combination of selumetinib with olaparib, or selumetinib alone, for RAS pathway-mutant recurrent or persistent …
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression [Phase 2]
Phase 2 study investigating niraparib rechallenge after surgery in ovarian cancer patients with oligometastatic progression; currently recru…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of PHST001 in Advanced Solid Tumors [Phase 1]
Pheast Therapeutics is recruiting for a Phase 1 study of PHST001 in patients with advanced solid tumors, including ovarian cancer, endometri…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Trial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer Patients [Phase 1]
This clinical trial update indicates that THEO-260 is being studied via intraperitoneal administration in ovarian cancer and is currently re…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer [Phase 1]
Phase 1 trial evaluating DT2216 in combination with paclitaxel for platinum-resistant ovarian cancer. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial of BMS-986500 as monotherapy or in combination for advanced solid tumors, including advanced breast cancer and advanc…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors [Phase 1]
NiKang Therapeutics is conducting a Phase 1 study of NKT3964 in adults with advanced or metastatic solid tumors, and the trial is currently …
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence [Phase 1]
Phase 1 clinical trial at University of Colorado, Denver evaluating psilocybin-assisted psychotherapy to address fear of recurrence in breas…